11/05/2024 6:29 PM | CRCM LP (Filed by) Singular Genomics Systems (Subject)
| Form SC 13D | |
11/04/2024 6:30 AM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 6:54 PM | Flynn James E (Filed by) Singular Genomics Systems (Subject)
| Form SC 13D/A | |
10/03/2024 5:00 PM | Ghai Jyotsna (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 4:27 PM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2024 3:31 PM | Singular Genomics Systems (Issuer) TANG CAPITAL MANAGEMENT LLC (Reporting) TANG CAPITAL PARTNERS LP (Reporting) TANG KEVIN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:26 PM | Singular Genomics Systems (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
|
09/17/2024 6:35 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:36 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:36 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:35 PM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 3:07 PM | Flynn James E (Filed by) Singular Genomics Systems (Subject)
| Form SC 13D | |
08/13/2024 4:05 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 4:06 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 4:08 PM | Ghai Jyotsna (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 7:26 AM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 4:23 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 4:24 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 4:24 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:30 PM | Pellini Michael J (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:30 PM | Ryan Jason (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:30 PM | BARKER DAVID L (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:31 PM | Kamdar Kim P. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:32 PM | Mardis Elaine R (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:32 PM | Eisenberg Marcia (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:31 PM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:09 PM | Singular Genomics Systems (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 3:06 PM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:00 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 6:00 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 6:01 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 6:01 PM | Ghai Jyotsna (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 3:30 PM | Singular Genomics Systems (Filer)
| Form DEF 14A | |
04/18/2024 3:31 PM | Singular Genomics Systems (Filer)
| Form DEFA14A | |
04/18/2024 3:32 PM | Singular Genomics Systems (Filer)
| Form ARS | |
04/05/2024 3:30 PM | Singular Genomics Systems (Filer)
| Form PRE 14A | |
03/19/2024 4:46 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 4:47 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 4:48 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 4:49 PM | Ropp Sam (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:01 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
02/13/2024 5:02 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:03 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:04 PM | Ropp Sam (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:05 PM | Ghai Jyotsna (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 4:31 PM | Flynn James E (Filed by) Singular Genomics Systems (Subject)
| Form SC 13G/A | |
01/19/2024 3:29 PM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 5:01 AM | Singular Genomics Systems (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 4:41 PM | Glezer Eli N. (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:42 PM | Meeter Dalen (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:44 PM | Ropp Sam (Reporting) Singular Genomics Systems (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:39 PM | Singular Genomics Systems (Issuer) Spaventa Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |